Compare M & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | M | TFX |
|---|---|---|
| Founded | 1830 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.6B |
| IPO Year | 2002 | 1994 |
| Metric | M | TFX |
|---|---|---|
| Price | $19.59 | $120.33 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 8 |
| Target Price | $20.09 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 4.3M | 894.3K |
| Earning Date | 05-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.97% | 1.02% |
| EPS Growth | ★ 12.08 | N/A |
| EPS | ★ 2.32 | N/A |
| Revenue | ★ $22,621,000,000.00 | $1,992,713,000.00 |
| Revenue This Year | N/A | $15.97 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | $8.46 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.99 | $100.18 |
| 52 Week High | $24.41 | $139.67 |
| Indicator | M | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 43.94 |
| Support Level | $19.00 | $117.09 |
| Resistance Level | $20.95 | $126.13 |
| Average True Range (ATR) | 0.55 | 4.75 |
| MACD | -0.02 | -1.71 |
| Stochastic Oscillator | 34.38 | 0.41 |
Founded in 1858 and based in New York City, Macy's operates about 430 eponymous stores, 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constituted 64% of 2025 net retail sales.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.